Greenwood Capital Associates »

Madrigal Pharmaceuticals shares owned by Greenwood Capital Associates

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Greenwood Capital Associates from 13F filings

Historical chart of Greenwood Capital Associates investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Greenwood Capital Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Greenwood Capital Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $357k 682 523.47

More positions owned by Greenwood Capital Associates

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
J P Morgan Exchange Traded F Betabuilders Eur (BBEU)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Dimensional Etf Trust World Ex Us Core (DFAX)
Ishares Msci Emrg Chn (EMXC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Intrm Gov Cr Etf (GVI)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Pac (IPAC)
Ishares Tr Core Msci Total (IXUS)
International Business Machines (IBM)
Johnson & Johnson (JNJ)

View all positions for Greenwood Capital Associates

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Henderson Group
Rtw Investments
Vanguard Group
venBio Select Advisor
BlackRock
Paulson & Co
Vanguard Portfolio Management
Vanguard Capital Management
Citadel Advisors
State Street Corporation
Wellington Management Company
Geode Capital Management
FMR
William Blair Investment Management

View all funds holding Madrigal Pharmaceuticals